China Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from China life sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In China Life Sciences Today - Breaking & Trending Today

New findings expand the genotypic spectrum of NPRL3-associated focal epilepsy

Science China Life Sciences magazine recently reported on the research results of Tang Beisha's team from Xiangya Hospital of Central South University, Liu Jing Yu's team from the Institute of Neurology of the Chinese Academy of Sciences, and Zhang Luoying's team from Huazhong University of Science and Technology, including Du Shiyue, Zeng Sheng, and Song Li. Epilepsy has a complex etiology with 80% owing a genetic basis. ....

Song Li , Zeng Sheng , Jingyu Liu , Beisha Tang , Tang Beisha , Zhang Luoying , Liu Jing Yu , Lily Ramsey , Science China Life Sciences , Huazhong University Of Science , Xiangya Hospital Of Central South University , China Life Sciences , Xiangya Hospital , Central South University , Chinese Academy , Huazhong University ,

Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy

Functional characterization of novel NPRL3 mutations identified in three families with focal epilepsy
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Zeng Sheng , Song Li , Jingyu Liu , Liu Jing Yu , Zhang Luoying , Tang Beisha , Beisha Tang , Xiangya Hospital Of Central South University , Science China , Huazhong University Of Science , Science China Life Sciences , Science China Press , China Life Sciences , Xiangya Hospital , Central South University , Chinese Academy , Huazhong University , Science China Life ,

Ropes & Gray Advises Everest Medicines on Agreement with Gilead Sciences for Cancer Drug Trodelvy in Asia Territories

Everest Medicines, advised by Ropes & Gray, announced on Aug. 16, 2022, that it has entered into an agreement with Immunomedics, Inc. under which Immunomedics will obtain exclusive rights to develop and commercialize cancer drug Trodelvy in Asia territories. ....

Hong Kong , United States , Republic Of , South Korea , Asia Pacific , Immunomedics Inc , China Life Sciences , Gilead Sciences , Life Sciences Licensing , Gilead Sciences For Cancer Drug Trodelvy , Gray Advises Everest Medicines , Cancer Drug Trodelvy , Asia Territories , Strategic Licensing Programs , Joint Ventures , Strategic Commercial ,